NDC 29033-001
Theophylline(Anhydrous) 400 mg tablet, extended release
On the label: Nostrum Laboratories, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Nostrum Laboratories, Inc. | Bryan, Ohio, United States | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyMar 13, 2025 · 6 inspections |
Recalls
- Mar 6, 2020 · Class II · Nostrum Laboratories Inc
CGMP Deviations: poor manufacturing practices resulted in Labeling: Incorrect or Missing Lot and/or Exp Date, product incorrectly labeled with incorrect lot and expiration date.
Lots: Lot: THE190501, Exp 11/2022
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Theophylline: every company that makes it
- Form
- tablet, extended release
- Strength
- 400 mg
- Approval
- ANDA ANDA040560
- On the market since
- Jan 23, 2020
- Package NDCs
29033-001-01- Official label
- DailyMed (National Library of Medicine), updated Nov 1, 2021
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?